Delphia (USA)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,367
Closed -$230K 208
2023
Q2
$230K Sell
6,367
-134
-2% -$4.84K 0.36% 128
2023
Q1
$242K Buy
+6,501
New +$242K 0.3% 160
2022
Q4
Sell
-4,873
Closed -$340K 377
2022
Q3
$340K Sell
4,873
-1,084
-18% -$75.6K 0.39% 87
2022
Q2
$400K Buy
+5,957
New +$400K 0.28% 115